Cargando…
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Patients with coronavirus disease-19 (COVID-19) are at high risk for thrombotic arterial and venous occlusions. However, bleeding complications have also been observed in some patients. Understanding the balance between coagulation and fibrinolysis will help inform optimal approaches to thrombosis p...
Autores principales: | Zuo, Yu, Warnock, Mark, Harbaugh, Alyssa, Yalavarthi, Srilakshmi, Gockman, Kelsey, Zuo, Melanie, Madison, Jacqueline A., Knight, Jason S., Kanthi, Yogendra, Lawrence, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810990/ https://www.ncbi.nlm.nih.gov/pubmed/33452298 http://dx.doi.org/10.1038/s41598-020-80010-z |
Ejemplares similares
-
Autoantibodies stabilize neutrophil extracellular traps in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021) -
Endothelial Cell–Activating Antibodies in COVID‐19
por: Shi, Hui, et al.
Publicado: (2022) -
Neutrophil extracellular traps and thrombosis in COVID-19
por: Zuo, Yu, et al.
Publicado: (2020) -
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
por: Shi, Hui, et al.
Publicado: (2020) -
The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)